Abstract Posters 1119: Skin and other diseases

Tuesday, 7 December 2010: 13:00 - 14:15
Chairpersons:   Salem H. Al-Tamemi and Barbara Rogala
Comparative evaluation of epidemiological factors and complications of cataract surgery in diabetic patients versus non diabetic patients
Effect of a synbiotic mixture on atopic dermatitis in children: A randomized-controlled trial
Efficacy of omalizumab monotherapy in the management of atopic dermatitis
Effectiveness of omalizumab in the treatment of cold urticaria
The active form of d vitamin, calcitriol 1,25(OH)2D3 and natural PPRgamma agonist, -3 polyunsaturated fatty acids (PUFAs) might serve as a negative feedback loop to prevent excessive inflammation in patients with severe atopic dermatitis
Methotrexate for urticarial vasculitis and angioedema with cryoglobulinemia
Anti-IgE (omalizumab) effective as single-drug therapy for chronic idiopathic urticaria
Patient with vasculitic autoimmune and PRESSURE urticaria successfully treated with omalizuamb
Open-label use of nanofiltered C1 esterase inhibitor (human) for the treatment of hereditary angioedema (HAE) attacks
Open-Label Use of Nanofiltered C1 Esterase Inhibitor (Human) for the Prophylaxis of Hereditary Angioedema (HAE) Attacks
Open-label use of Nanofiltered C1 Esterase Inhibitor (human) (nf-C1INH) for treatment of acute attacks of Hereditary Angioedema (HAE) in pediatric subjects
Open-label Use of Nanofiltered C1 Esterase Inhibitor (human) (nf-C1 INH) for the Prophylaxis of Attacks of Hereditary Angioedema (HAE) in Pediatric Subjects
Open-label use of Nanofiltered C1 Esterase Inhibitor (human) for Treatment or Prophylaxis of Acute Attacks of Hereditary Angioedema (HAE) in Pregnant Subjects
See more of: Poster Session 2
See more of: Abstract Submission
<< Previous Session | Next Session >>